Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 26.10
-0.90 (-3.33%)
At close: Mar 3, 2026
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 5.22 billion as of March 3, 2026. Its market cap has increased by 30.53% in one year.
Market Cap
5.22B
Enterprise Value
4.47B
Revenue
5.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.10
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 5.22B, a decrease of -47.15%. That is a compound annual growth rate of -15.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 5.40B | -6.09% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 5.93B |
| Sinphar Pharmaceutical | 5.83B |
| CHO Pharma | 5.62B |
| Steminent Biotherapeutics | 5.62B |
| AnnJi Pharmaceutical | 5.60B |
| OBI Pharma | 5.33B |
| Panion & Bf Biotech | 5.29B |
| UnicoCell Biomed | 5.22B |